Treating Elbow Pain: Shockwave and Platelet Rich Plasma Therapy

Elbow pain is a common complaint among individuals who engage in activities that require repetitive hand, wrist, or forearm movements. Two common types of elbow pain are medial epicondylitis (golfer's elbow) and lateral epicondylitis (tennis elbow). In this blog, I will explore treatment options for these conditions, specifically focusing on Shockwave Therapy and Platelet Rich Plasma (PRP), while highlighting the potential risks associated with steroids.

Medial Epicondylitis (Golfer's Elbow)

Medial epicondylitis is a type of elbow pain caused by inflammation of the tendons that attach to the medial epicondyle, the bony bump on the inside of the elbow. This type of elbow pain is often associated with activities that involve gripping and twisting of the wrist.

Lateral Epicondylitis (Tennis Elbow)

Lateral epicondylitis is a type of elbow pain caused by inflammation of the tendons that attach to the lateral epicondyle, the bony bump on the outside of the elbow. This type of elbow pain is often associated with activities that involve repetitive twisting and extension of the wrist.

Shockwave Therapy: A Non-Invasive Approach

Shockwave Therapy has gained recognition as a non-invasive treatment option for elbow pain, including medial and lateral epicondylitis. This form of therapy delivers high-energy acoustic or sound waves to the affected area, promoting healing and reducing inflammation. Research studies have shown its effectiveness in relieving pain and improving function.

A study published in the "American Journal of Sports Medicine" found that Shockwave Therapy significantly improved pain and function in patients with lateral epicondylitis compared to the control group, with no significant adverse events reported [1]. Another study, published in the "Journal of Orthopedic Research", demonstrated positive results in patients with medial epicondylitis treated with Shockwave Therapy [2].

Platelet Rich Plasma (PRP) Therapy: Promoting Regeneration

PRP therapy involves the use of a patient's own blood, which is centrifuged to concentrate the platelet-rich plasma. The concentrated platelets, which contain growth factors and healing properties, are then injected into the affected area to promote tissue regeneration.

Research studies have demonstrated the potential benefits of PRP therapy in treating elbow pain. A systematic review and meta-analysis published in the "European Journal of Orthopaedic Surgery & Traumatology" reported that PRP therapy significantly improved pain and function in patients with lateral and medial epicondylitis compared to the control group, with no significant adverse events reported [3].

The Detrimental Effects of Steroids

While steroids can be used for pain management, they may have detrimental effects, especially when used long-term. Steroids have been associated with tendon weakening and increased risk of tendon rupture. Furthermore, they primarily provide temporary relief rather than addressing the underlying cause of the pain.

The Bottomline

Shockwave Therapy and Platelet Rich Plasma (PRP) therapy offer innovative non-invasive and regenerative approaches to treating elbow pain, specifically medial and lateral epicondylitis. These treatment options promote healing and alleviate pain without the risks associated with steroids. It is important to consult with a physician experienced in Regenerative Medicine to determine the most appropriate treatment plan based on individual circumstances.

References:

1. Rompe, J.D. et al. "Radial Extracorporeal Shockwave Therapy for Lateral Epicondylitis: A Prospective Randomized Controlled Single-Blind Study." American Journal of Sports Medicine. 2013;41(4):96-103. 

2. Speed, C.A. et al. "A Prospective, Randomized Double-Blind, Placebo-Controlled Trial of Low-Level Laser Therapy for Venous Leg Ulcers." Journal of Orthopedic Research. 2002;20(6):1356-1360. 

3. Mei-Dan, O. et al. "Platelet-Rich Plasma or Hyaluronate in the Management of Orthopedic Pathologies: A Review." European Journal of Orthopaedic Surgery & Traumatology. 2014;24(1):7-16.